Utility of the Intradermal Skin Test in a Test-and-Cull Approach to Control Bovine Tuberculosis: A Pilot Study in Ethiopia.
Ethiopia
bovine tuberculosis
control program
prevalence
test and cull
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
11
2021
accepted:
17
01
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Bovine tuberculosis (bTB) is one of the top three, high-priority, livestock diseases in Ethiopia and hence, the need for evaluation of potential control strategies is critical. Here, we applied the test-and-segregate followed by cull strategy for the control of bTB in the intensive Alage dairy farm in Ethiopia. All cattle reared on this farm were repeatedly skin tested using the Comparative Cervical Tuberculin (CCT) test for a total of five times between 2015 and 2021. During the first (October 2015) and second (March 2017) rounds of testing, all reactor animals (>4 mm) were culled, while those that were deemed as inconclusive (1-4 mm) were segregated and retested. At retest, animals with CCT >2 mm were removed from the herd. In the third (December 2017) and fourth (June 2018) rounds of tuberculin testing, a more stringent approach was taken wherein all reactors per the severe mode of CCT test interpretation (>2 mm) were culled. A final herd status check was performed in May 2021. In summary, the number of CCT positives (>4 mm) in the farm dropped from 23.1% (31/134) in October 2015 to 0% in December 2017 and remained 0% until May 2021. In contrast, the number of Single Cervical Tuberculin (SCT) test positives (≥4 mm) increased from 1.8 to 9.5% (from 2017 to 2021), indicating that CCT test might not be sufficient to effectively clear the herd of bTB. However, a more stringent approach would result in a drastic increase in the number of false positives. The total cost of the bTB control effort in this farm holding 134-200 cattle at any given time was conservatively estimated to be ~US$48,000. This, together with the need for culling an unacceptably high number of animals based on skin test status, makes the test-and-cull strategy impractical for nationwide implementation in Ethiopia and other low- and middle-income countries (LMICs) where the infection is endemic. Hence, there is an increased emphasis on the need to explore alternate, affordable measures such as vaccination alongside accurate diagnostics to help control bTB in endemic settings.
Identifiants
pubmed: 35330613
doi: 10.3389/fvets.2022.823365
pmc: PMC8940234
doi:
Types de publication
Journal Article
Langues
eng
Pagination
823365Informations de copyright
Copyright © 2022 Lakew, Srinivasan, Mesele, Olani, Koran, Tadesse, Mekonnen, Almaw, Sahlu, Seyoum, Beyecha, Gumi, Ameni, Ashenafi, Bakker, Kapur and Gebre.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Transbound Emerg Dis. 2018 Feb;65(1):96-104
pubmed: 28168855
Vet Rec. 2015 Sep 5;177(9):224-32
pubmed: 26338937
Lancet. 2015 May 2;385(9979):1799-1801
pubmed: 25814376
Vet Rec. 2007 Dec 8;161(23):782-6
pubmed: 18065813
Prev Vet Med. 2017 Nov 1;147:149-157
pubmed: 29254713
Rev Sci Tech. 2001 Apr;20(1):71-85
pubmed: 11288521
Prev Vet Med. 2019 Dec 1;173:104805
pubmed: 31715496
Maedica (Bucur). 2013 Mar;8(1):53-8
pubmed: 24023600
Aust Vet J. 1991 Sep;68(9):286-90
pubmed: 1953560
Res Vet Sci. 1990 Jul;49(1):46-9
pubmed: 2116655
PLoS One. 2012;7(12):e52851
pubmed: 23285202
Clin Vaccine Immunol. 2008 Aug;15(8):1272-6
pubmed: 18495847
Front Vet Sci. 2020 Jul 24;7:391
pubmed: 32793643
J Clin Microbiol. 2010 Sep;48(9):3176-81
pubmed: 20592155
Sci Rep. 2021 Feb 3;11(1):2929
pubmed: 33536465
Vet Microbiol. 2006 Feb 25;112(2-4):101-9
pubmed: 16388921
Vet Med Int. 2011;2011:816345
pubmed: 21647341
Front Vet Sci. 2021 Feb 18;8:637580
pubmed: 33681334
Sci Adv. 2019 Jul 17;5(7):eaax4899
pubmed: 31328169
Prev Vet Med. 2019 Jul 1;168:81-89
pubmed: 31097127
Transbound Emerg Dis. 2021 Jul 31;:
pubmed: 34331511